| Global healthcare expenditure on diabetes for 2010 and 2030 P Zhang, X Zhang, J Brown, D Vistisen, R Sicree, J Shaw, G Nichols Diabetes research and clinical practice 87 (3), 293-301, 2010 | 1543 | 2010 |
| GLP-1 response to oral glucose is reduced in prediabetes, screen-detected type 2 diabetes, and obesity and influenced by sex: the ADDITION-PRO study K Færch, SS Torekov, D Vistisen, NB Johansen, DR Witte, A Jonsson, ... Diabetes 64 (7), 2513-2525, 2015 | 281 | 2015 |
| Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups DL Christensen, DR Witte, L Kaduka, ME Jørgensen, K Borch-Johnsen, ... Diabetes care 33 (3), 580-582, 2010 | 225 | 2010 |
| Insulin resistance is accompanied by increased fasting glucagon and delayed glucagon suppression in individuals with normal and impaired glucose regulation K Færch, D Vistisen, G Pacini, SS Torekov, NB Johansen, DR Witte, ... Diabetes 65 (11), 3473-3481, 2016 | 182 | 2016 |
| Risk scores for type 2 diabetes can be applied in some populations but not all C GLumer, D Vistisen, K Borch-Johnsen, S Colagiuri, ... Diabetes care 29 (2), 410-414, 2006 | 176 | 2006 |
| Prediction of first cardiovascular disease event in type 1 diabetes mellitus: the steno type 1 risk engine D Vistisen, GS Andersen, CS Hansen, A Hulman, JE Henriksen, ... Circulation 133 (11), 1058-1066, 2016 | 160 | 2016 |
| There really is an epidemic of type 2 diabetes S Colagiuri, K Borch-Johnsen, C Glümer, D Vistisen Diabetologia 48, 1459-1463, 2005 | 155 | 2005 |
| Risk of cardiovascular disease and death in individuals with prediabetes defined by different criteria: the Whitehall II study D Vistisen, DR Witte, EJ Brunner, M Kivimäki, A Tabak, ME Jørgensen, ... Diabetes Care 41 (4), 899-906, 2018 | 151 | 2018 |
| Determinants of aortic stiffness: 16-year follow-up of the Whitehall II study NB Johansen, D Vistisen, EJ Brunner, AG Tabák, MJ Shipley, ... PloS one 7 (5), e37165, 2012 | 128 | 2012 |
| Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study K Færch, DR Witte, AG Tabák, L Perreault, C Herder, EJ Brunner, ... The lancet Diabetes & endocrinology 1 (1), 43-51, 2013 | 118 | 2013 |
| Progressive decline in estimated glomerular filtration rate in patients with diabetes after moderate loss in kidney function—even without albuminuria D Vistisen, GS Andersen, A Hulman, F Persson, P Rossing, ... Diabetes Care 42 (10), 1886-1894, 2019 | 115 | 2019 |
| The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for … M Alssema, D Vistisen, MW Heymans, G Nijpels, C Glümer, PZ Zimmet, ... Diabetologia 54, 1004-1012, 2011 | 101 | 2011 |
| Patterns of obesity development before the diagnosis of type 2 diabetes: the Whitehall II cohort study D Vistisen, DR Witte, AG Tabák, C Herder, EJ Brunner, M Kivimäki, ... PLoS medicine 11 (2), e1001602, 2014 | 100 | 2014 |
| Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the … A Hulman, RK Simmons, EJ Brunner, DR Witte, K Færch, D Vistisen, ... Diabetologia 60, 1252-1260, 2017 | 85 | 2017 |
| Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids NJ Wewer Albrechtsen, K Færch, TM Jensen, DR Witte, J Pedersen, ... Diabetologia 61, 671-680, 2018 | 84 | 2018 |
| Sleep duration and sleep quality are associated differently with alterations of glucose homeostasis S Byberg, ALS Hansen, DL Christensen, D Vistisen, M Aadahl, ... Diabetic Medicine 29 (9), e354-e360, 2012 | 82 | 2012 |
| Metabolically healthy obesity and ischemic heart disease: a 10-year follow-up of the Inter99 study L Hansen, MK Netterstrøm, NB Johansen, PF Rønn, D Vistisen, ... The Journal of Clinical Endocrinology & Metabolism 102 (6), 1934-1942, 2017 | 81 | 2017 |
| Reversion from prediabetes to normoglycaemia and risk of cardiovascular disease and mortality: the Whitehall II cohort study D Vistisen, M Kivimäki, L Perreault, A Hulman, DR Witte, EJ Brunner, ... Diabetologia 62, 1385-1390, 2019 | 80 | 2019 |
| Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study C Herder, K Færch, M Carstensen-Kirberg, GD Lowe, R Haapakoski, ... European journal of endocrinology 175 (5), 367-377, 2016 | 72 | 2016 |
| HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis S Soulimane, D Simon, WH Herman, C Lange, CMY Lee, S Colagiuri, ... Diabetologia 57, 30-39, 2014 | 70 | 2014 |
Daniel R. WitteAarhus UniversityVerified email at ph.au.dk
